A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery
- Conditions
- Multiple SclerosisAmyotrophic Lateral Sclerosis (ALS)Alzheimer's DiseaseParkinson's DiseaseHuntington's Disease
- Registration Number
- NCT01592552
- Lead Sponsor
- Sanguine Biosciences
- Brief Summary
The purpose of this research project is to collect and store blood samples and clinical data. Researchers can then use the stored samples in future studies. Through such studies, they hope to find new ways to detect, treat, and maybe even prevent or cure health problems.
- Detailed Description
Blood samples are collected in the comfort and safety of your home by a certified medical professional. We have mobile phlebotomists located in major metropolitan areas around the nation for your convenience.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
- Males and females >18 to 100 years old
- A diagnosis of neurological condition
- Proof of diagnosis can be provided
Control group: Healthy donors, males and females, 18 to 100 years of age
Exclusion Criteria
- Receipt of blood products within 30 days of study enrollment
- Receipt of an investigational (unapproved) drug within 30 days of study enrollment
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Biospecimens & Clinical Data collection from patients with neurological diseases. 2 years The purpose of this research project is to collect and store blood samples and clinical data. Researchers can then use the stored samples in future studies. Through such studies, they hope to find new ways to detect, treat, and maybe even prevent or cure health problems.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Sanguine Biosciences
🇺🇸Sherman Oaks, California, United States